Latest News

Hanmi Secures Export Deal with Mexican Partner Sanfer for GLP-1 Obesity Drug and More

Hanmi Signs Exclusive Partnership with New Mexican Partner Laboratorios Sanfer, Covering Efpeglenatide and Diabetes Treatments  SEOUL, South Korea, Jan. 27, 2026 /PRNewswire/ -- Hanmi is accelerating its global market entry with efpeglenatide, Korea's first domestically developed GLP-1 class obes...

2026-01-28 12:08 3381

Singapore Eye Research Institute tops ScholarGPS rankings in Ophthalmology

* The Institute has placed #1 in ophthalmology among all non-academic institutes, and #2 in the same field among all institutes, globally. SINGAPORE, Jan. 27, 2026 /PRNewswire/ -- The Singapore Eye Research Institute (SERI) has achieved a landmark milestone inDecember 2025 by securing first pla...

2026-01-28 10:00 2849

MegazoneCloud and Hana Bank Partner to Develop Innovative Digital Financial Services

* Co-development of innovative financial services powered by advanced digital technologies such as AI, cloud, and data science * Strategic cooperation on trade finance for large-scale GPU and NPU server imports aligned with the government's Global Top 3 AI initiative SEOUL, South Korea, Jan. ...

2026-01-28 09:51 3093

Enhancing Workflow Efficiency with Monport's Fiber Laser and CO2 Laser Systems This Winter

NEW YORK, Jan. 27, 2026 /PRNewswire/ -- As manufacturers and creative professionals seek ways to maximize productivity, advanced laser systems have become a critical tool for precision, speed, and versatility.Fiber laser engravers for metal

2026-01-28 07:08 2808

Dreame Unveils "Beyond Smart" Home Ecosystem in Silicon Valley, Showcasing a Future of Robotic Autonomy and AI-Powered Living

SAN FRANCISCO, Jan. 27, 2026 /PRNewswire/ -- Dreame Technology,   a global leader in high-end consumer electronics and intelligent manufacturing, today launched its visionary 2026 home appliance lineu...

2026-01-28 06:00 3791

Finding each other through the algorithm: one year as a 'local' on China's social media: Global Times

BEIJING, Jan. 27, 2026 /PRNewswire/ -- Many American users who initially joined Xiaohongshu, a Chinese app for sharing daily life, a year ago following a looming TikTok ban - often referred to as "TikTok refugees" - have become what they now call "Xiaohongshu locals." Netizens fromChina and the U...

2026-01-27 23:41 4463

Official Launch: The World's First AI Platform Built Specifically for Family Life

Introducing Nori, a system-level AI designed for shared coordination across modern families SAN FRANCISCO, Jan. 27, 2026 /PRNewswire/ -- Domus Next Inc. today announced the launch of Nori, the world's first AI built specifically for family life. Designed from inception as a shared system rather ...

2026-01-27 23:39 3319

AllsWell Marks Consecutive Appearances at CES: From Managed Brand PR to GEO, Advancing Brand Growth in the Generative Search Era

At CES 2026, AllsWell Announces Strategic Partnership with LEAP GEO to Help Brands Move from Exposure to AI Citations and Recommendations LAS VEGAS, Jan. 27, 2026 /PRNewswire/ -- Global brand communications and public relations consultancyAllsWell announced at the 2026 Consumer Electronics Show ...

2026-01-27 23:15 4539

FutureMain Bolsters Global Industrial AI Competitiveness with NPU-Based Time-Series AI Project

SEOUL, South Korea, Jan. 27, 2026 /PRNewswire/ -- FutureMain Co., Ltd. , a specialized industrial AI company focused on equipment diagnostics and predictive maintenance, announced that it is playing a pivotal role in a next-generation intelligent semiconductor R&D proj...

2026-01-27 22:00 3278

Insilico Medicine and Qilu Pharmaceutical Reach Near $120 Million Drug Development Collaboration to Accelerate Novel Cardiometabolic Therapies

CAMBRIDGE, Mass., Jan. 27, 2026 /PRNewswire/ -- Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern pharmaceutical enterprise in China, as well as its subsidiary Shanghai Qilu Pharmaceutical Research Center...

2026-01-27 22:00 5405

Asthma and Allergy Drug Development Is Failing Too Often--A Translational Reset Is Needed: HKEY-AIRx™1.0

BOSTON and SUZHOU, China, Jan. 27, 2026 /PRNewswire/ -- HKeyBio, a preclinical CRO focused on autoimmune and allergic disease drug development, today announced a translational preclinical strategy,HKEY-AIRxTM1.0  designed to address one of the most persistent problems facing biotech leadership: w...

2026-01-27 22:00 4834

Combatting the Energy Crisis: Eworld Showcases Low-Energy Glass Processing Machinery and Sustainable Solutions at Major Global Expos

International trade shows highlight Eworld's energy-efficient glass processing technologies for architectural and industrial applications JINAN, China, Jan. 27, 2026 /PRNewswire/ -- High energy costs and tightening environmental regulations are no longer just future concerns; they are the immedi...

2026-01-27 21:47 5047

Tineco Elevates Modern Living With a Smarter, More Balanced Floor Care Portfolio

SEATTLE, Jan. 27, 2026 /PRNewswire/ -- As modern homes continue to evolve, consumers are increasingly seeking appliances that combine performance, thoughtful design, and long-term value.Tineco , a leader in intelligent floor care solutions, brings this philosophy to life ...

2026-01-27 21:46 3323

Beetles Gel Polish Celebrates 5-Star Women's Basketball Recruit Jerzy Robinson's College Commitment

Top ranked women's basketball recruit Jerzy Robinson marks a defining life chapter through self-expression with Beetles Gel Polish. NEW YORK, Jan. 27, 2026 /PRNewswire/ -- As young athletes navigate high-pressure moments both on and off the court, Beetles Gel Polish reinforces its long-standing ...

2026-01-27 21:32 3735

Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late-Stage Metastatic Triple-Negative Breast Cancer

SYDNEY, Jan. 27, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), today provided a clinical update from its ongoing Phase1b study evaluating paxalisib in combination with pembrolizumab and chemotherapy in patients with late-stage (Stage IV), metastatic triple-negative breast cancer (TNBC)....

2026-01-27 21:00 6675

From creation to product promotion, they are using AIGC's CreatOK video technology to reap dividends in bulk

BEIJING, Jan. 26, 2026 /PRNewswire/ -- Nowadays, the majority of users are no longer unfamiliar with AI text-to-video technology. On various social media platforms, creative videos using AI technology, such as dancing kittens, "AI Shelter", and "AI comic-style selfies", have long been commonplace...

2026-01-27 19:31 3584

Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammatory bowel disease

* Novel TL1A/IL23p19 bispecific antibody targets drivers of disease pathogenesis to overcome the efficacy ceiling in inflammatory bowel disease. * License and collaboration agreement strengthen Boehringer's inflammatory disease pipeline with a potential, first-in-class, pre-clinical asset. *...

2026-01-27 18:40 4388

Libevitug Approved in China as First-in-Class Treatment for Hepatitis D

BEIJING, Jan. 27, 2026 /PRNewswire/ -- Huahui Health announced that China National Medical Products Administration (NMPA) has granted conditional approval to its Libevitug injection for the treatment of chronic hepatitis D virus infection in adults with or without compensated cirrhosis. Libevitug...

2026-01-27 16:18 3429

Nexdata Announces Completion and Full Operation of Its World-Class Embodied AI Data Collection Factory

SINGAPORE, Jan. 27, 2026 /PRNewswire/ -- As embodied AI rapidly evolves from foundation models and software-based agents toward real-world intelligent robots, the industry is facing a critical bottleneck: the large-scale availability of high-quality, real physical interaction data. Addressing thi...

2026-01-27 15:55 4018

ROHM's New LDO Regulators with 500mA Output Current Achieve Stable Operation Even with Ultra-small Capacitors

KYOTO, Japan, Jan. 27, 2026 /PRNewswire/ -- ROHM Co., Ltd. has developed the "BD9xxN5 Series" of LDO regulator ICs with 500mA output current, featuring its proprietary ultra-stable control technology "Nano Cap (TM)." This series is designed for 12V/24V primary power supply applications used in au...

2026-01-27 15:00 2951
1 ... 891011121314 ... 1677